Bariatric Surgery Cuts Cancer Risk With Obesity + Liver Disease
Bariatric surgery is associated with significant reductions in the risks for any cancer and obesity-related cancer in nonalcoholic fatty liver disease patients with severe obesity.
Bariatric surgery is associated with significant reductions in the risks for any cancer and obesity-related cancer in nonalcoholic fatty liver disease patients with severe obesity.
The American Gastroenterological Association (AGA) has issued a clinical practice update regarding bariatric surgery in cirrhosis.
The investigators aimed to report on early experience with OAGB compared to RYGB in terms of complication rates.
C. Andrew Kistler, MD, PharmD, examines existing data about bariatric surgery and the risk for subsequent colorectal cancer development.
This study examines the clinical characteristics that predict durable long-term diabetes remission after bariatric surgery.
A team of investigators conducted a retrospective review of records to determine the effect of gastric bypass surgery on patients with type 2 diabetes and comorbid liver steatosis.
Many bariatric surgery patients do not receive recommended postoperative nutritional and weight monitoring within general practice.
A team of investigators sought to assess the effects of a supervised exercise program on bone mass in individuals having undergone bariatric surgery.
Laparoscopic Roux-en-Y gastric bypass results in greater weight loss than laparoscopic sleeve gastrectomy seven years after surgery.
Investigators evaluated the impact of bariatric surgery on carotid intima-media thickness (CIMT) and the risk for cardiovascular disease (CVD) in patients with morbid obesity.